Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Genet Med. 2015 Mar 5;17(5):405–424. doi: 10.1038/gim.2015.30

Table 4.

Criteria for Classifying Benign Variants

Stand-Alone evidence of benign impact
BA1 Allele frequency is above 5% in Exome Sequencing Project, 1000 Genomes,
or ExAC
Strong evidence of benign impact
BS1 Allele frequency is greater than expected for disorder (see table 6)
BS2 Observed in a healthy adult individual for a recessive (homozygous),
dominant (heterozygous), or X-linked (hemizygous) disorder with full
penetrance expected at an early age
BS3 Well-established in vitro or in vivo functional studies shows no damaging
effect on protein function or splicing
BS4 Lack of segregation in affected members of a family
Caveat: The presence of phenocopies for common phenotypes (i.e. cancer,
epilepsy) can mimic lack of segregation among affected individuals. Also,
families may have more than one pathogenic variant contributing to an
autosomal dominant disorder, further confounding an apparent lack of
segregation.
Supporting evidence of benign impact
BP1 Missense variant in a gene for which primarily truncating variants are
known to cause disease
BP2 Observed in trans with a pathogenic variant for a fully penetrant dominant
gene/disorder; or observed in cis with a pathogenic variant in any
inheritance pattern
BP3 In-frame deletions/insertions in a repetitive region without a known
function
BP4 Multiple lines of computational evidence suggest no impact on gene or
gene product (conservation, evolutionary, splicing impact, etc)
Caveat: As many in silico algorithms use the same or very similar input for
their predictions, each algorithm cannot be counted as an independent
criterion. BP4 can be used only once in any evaluation of a variant.
BP5 Variant found in a case with an alternate molecular basis for disease
BP6 Reputable source recently reports variant as benign but the evidence is not
available to the laboratory to perform an independent evaluation
BP7 A synonymous (silent) variant for which splicing prediction algorithms
predict no impact to the splice consensus sequence nor the creation of a
new splice site AND the nucleotide is not highly conserved